BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17523765)

  • 1. High-Dose Torasemide is Equivalent to High-Dose Furosemide with Hypertonic Saline in the Treatment of Refractory Congestive Heart Failure.
    Paterna S; Fasullo S; Di Pasquale P
    Clin Drug Investig; 2005; 25(3):165-73. PubMed ID: 17523765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure.
    Parrinello G; Paterna S; Di Pasquale P; Torres D; Mezzero M; Cardillo M; Fasullo S; La Rocca G; Licata G
    J Card Fail; 2011 Apr; 17(4):331-9. PubMed ID: 21440872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
    Paterna S; Fasullo S; Parrinello G; Cannizzaro S; Basile I; Vitrano G; Terrazzino G; Maringhini G; Ganci F; Scalzo S; Sarullo FM; Cice G; Di Pasquale P
    Am J Med Sci; 2011 Jul; 342(1):27-37. PubMed ID: 21701268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
    Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
    Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torasemide: a pharmacoeconomic review of its use in chronic heart failure.
    Young M; Plosker GL
    Pharmacoeconomics; 2001; 19(6):679-703. PubMed ID: 11456215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
    Wan Y; Li L; Niu H; Ma X; Yang J; Yuan C; Mu G; Zhang J
    Int Heart J; 2017 Aug; 58(4):601-607. PubMed ID: 28701670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?
    Paterna S; Gaspare P; Fasullo S; Sarullo FM; Di Pasquale P
    Clin Sci (Lond); 2008 Feb; 114(3):221-30. PubMed ID: 17688420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure.
    Paterna S; Parrinello G; Amato P; Dominguez L; Pinto A; Maniscalchi T; Cardinale A; Licata A; Amato V; Licata G; Di Pasquale P
    Adv Ther; 1999; 16(5):219-28. PubMed ID: 10915397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torasemide in chronic heart failure: results of the TORIC study.
    Cosín J; Díez J;
    Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
    Díez J; Coca A; de Teresa E; Anguita M; Castro-Beiras A; Conthe P; Cobo E; Fernández E;
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):897-904. PubMed ID: 19673667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics and Pharmacodynamics Modeling of Torasemide and Furosemide After Oral Repeated Administration in Healthy Dogs.
    Pelligand L; Guillot E; Geneteau A; Guyonnet J; Magnier R; Elliott J; Peyrou M; Jacobs M
    Front Vet Sci; 2020; 7():151. PubMed ID: 32411731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
    Ballester MR; Roig E; Gich I; Puntes M; Delgadillo J; Santos B; Antonijoan RM
    Drug Des Devel Ther; 2015; 9():4291-302. PubMed ID: 26273191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
    Gandhi S; Mosleh W; Myers RB
    Int J Cardiol; 2014 May; 173(2):139-45. PubMed ID: 24679680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).
    Parrinello G; Di Pasquale P; Torres D; Cardillo M; Schimmenti C; Lupo U; Iatrino R; Petrantoni R; Montaina C; Giambanco S; Paterna S
    Am Heart J; 2012 Sep; 164(3):351-7. PubMed ID: 22980301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.